文献速递复苏、休克与脓毒症重症综合管理与镇静镇痛

大流行期间谁应升级至重症监护?英国COVID-19大流行期间决策的回顾性观察研究

Who to escalate during a pandemic? A retrospective observational study about decision-making during the COVID-19 pandemic in the UK.
PubMed 文献 · Emerg Med J · 2023-06-16
一句话结论在资源受限的大流行中,临床医生判定适合升级至重症监护的患者年龄更轻、CFS和4C评分更低;两波疫情间年龄、CFS及4C评分无显著差异,但未升级者死亡率第一波61.8%、第二波47.4%(p<0.001)。

本研究回顾性分析英国两次COVID-19疫情高峰(2020年3/4月为队列1,2021年10/11月为队列2)期间所有转诊至重症监护的患者,比较临床医生升级决策与年龄、临床衰弱评分(CFS)、4C死亡率评分及院内死亡率的关系。共纳入203例(队列1 139例,队列2 64例)。两队列间年龄、CFS和4C评分无显著差异;被临床医生判定适合升级者的年龄显著更轻、CFS和4C评分显著更低,此模式在两队列中均存在。未升级者死亡率队列1为61.8%、队列2为47.4%(p<0.001)。作者认为风险预测工具可能有助于补充临床决策,但升级阈值需根据大流行波次间的风险特征和结局变化进行调整。

要点

  • 被临床医生判定适合升级至重症监护者年龄显著更轻、CFS和4C评分显著更低,此模式在两次疫情高峰中均存在。
  • 未被判定适合升级者院内死亡率队列1为61.8%、队列2为47.4%(p<0.001)。
  • 两次疫情高峰间年龄、CFS和4C评分无显著差异。
  • 作者认为风险预测工具在大流行中可能有助于补充临床决策,但升级阈值需随不同大流行波次的风险特征和结局变化调整。
  • 作者指出在资源受限环境下决定谁升级至重症监护给临床医生带来道德困扰。

适用人群与场景

  • 确诊或高度临床怀疑COVID-19感染并转诊至重症监护的患者,来源于第一波疫情(队列1,2020年3月/4月)和晚发波次(队列2,2021年10月/11月)。
  • 由资深重症监护医师评估所有患者是否适合潜在的重症监护病房入住。

研究设计与关键结果

  • 研究类型:回顾性观察研究;共纳入203例患者,队列1(2020年3月/4月)139例,队列2(2021年10月/11月)64例。
  • 两队列间年龄、CFS和4C死亡率评分无显著差异。
  • 被临床医生判定适合升级者的年龄显著更轻、CFS和4C评分显著更低,与未被判定可从升级中获益者相比;此模式在两个队列中均观察到。
  • 未判定适合升级者的院内死亡率:队列1为61.8%,队列2为47.4%(p<0.001)。

证据类型、等级与局限

  • 证据类型:回顾性观察研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,风险预测工具在大流行中可能有助于补充临床决策,但升级阈值需调整以反映不同大流行波次间风险特征和结局的变化。
  • 作者指出,在资源受限环境下决定谁升级至重症监护给临床医生带来道德困扰。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Optimal decision-making regarding who to admit to critical care in pandemic situations remains unclear. We compared age, Clinical Frailty Score (CFS), 4C Mortality Score and hospital mortality in two separate COVID-19 surges based on the escalation decision made by the treating physician.

METHODS: A retrospective analysis of all referrals to critical care during the first COVID-19 surge (cohort 1, March/April 2020) and a late surge (cohort 2, October/November 2021) was undertaken. Patients with confirmed or high clinical suspicion of COVID-19 infection were included. A senior critical care physician assessed all patients regarding their suitability for potential intensive care unit admission. Demographics, CFS, 4C Mortality Score and hospital mortality were compared depending on the escalation decision made by the attending physician.

RESULTS: 203 patients were included in the study, 139 in cohort 1 and 64 in cohort 2. There were no significant differences in age, CFS and 4C scores between the two cohorts. Patients deemed suitable for escalation by clinicians were significantly younger with significantly lower CFS and 4C scores compared with patients who were not deemed to benefit from escalation. This pattern was observed in both cohorts. Mortality in patients not deemed suitable for escalation was 61.8% in cohort 1 and 47.4% in cohort 2 (p<0.001).

CONCLUSIONS: Decisions who to escalate to critical care in settings with limited resources pose moral distress on clinicians. 4C score, age and CFS did not change significantly between the two surges but differed significantly between patients deemed suitable for escalation and those deemed unsuitable by clinicians. Risk prediction tools may be useful in a pandemic to supplement clinical decision-making, even though escalation thresholds require adjustments to reflect changes in risk profile and outcomes between different pandemic surges.

来源:Emerg Med J,查看原文。版权归原作者所有。

参考来源

  1. Beresford S, Tandon A, Farina S, et al. Who to escalate during a pandemic? A retrospective observational study about decision-making during the COVID-19 pandemic in the UK. Emerg Med J. 2023. PMID: 37328261. doi:10.1136/emermed-2022-212505

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。